Skip to content

Clinical Performance of Dual-cantilevered Single-implant Bridge

Clinical Performance of a Novel Implant-supported Fixed Dental Prostheses (iFDP): the Dual-cantilevered Single-implant Bridge (T-bridge)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06099717
Acronym
T-bridge
Enrollment
50
Registered
2023-10-25
Start date
2024-06-30
Completion date
2026-10-01
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant Failed

Keywords

Dental implant

Brief summary

The study aims to evaluate the clinical performance (implant and prosthetic survival/ success rates) of a novel implant-supported fixed dental prosthesis design: the dual-cantilevered single implant bridge (T-Bridge) made out of monolithic zirconia bonded to a titanium base abutment (Variobase abutments)

Interventions

DEVICEDual-cantilevered implant bridge

A 3-unit supported by one implant in the middle

DEVICE3-unit iFDP

3-unit fixed dental prosthesis supported by two implants

Sponsors

University of Bern
Lead SponsorOTHER
ITI International Team for Implantology, Switzerland
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Group allocation

Intervention model description

Randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 20 years * Willingness to sign an informed consent and participate in the study * Three missing adjacent teeth in the posterior site. * Tooth gap of 21-24 mm. * Presence of natural or artificial opposing dentition * Sufficient vertical interocclusal space of an implant restoration (7mm) * Sufficient ridge height to place an implant of 10mm in length * Sufficient ridge width for the placement of a 4.1mm diameter implant. Simultaneous GBR to achieve a width of 6.5mm will be included.

Exclusion criteria

* Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance with the protocol * Any disorder that would interfere with wound healing or represent a contraindication for implant surgery, such as but not limited to uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates. * Pregnancy or lactation * Heavy smoking habit with ≥ 10 cig/d * Severe bruxism or clenching habits, presence of oro-facial pain * Insufficient ridge width/height for the study implant

Design outcomes

Primary

MeasureTime frameDescription
Implant and prosthetic success10 yearsPrimary outcome parameter: implant and prosthetic success Implant success and survival rate will be defined according to established criteria (Buser et al. 1991): A surviving implant and/or restoration is defined as are in place at the time of the follow-up.
Implant and prosthetic survival10 yearsImplant success and survival rate will be defined according to established criteria (Buser et al. 1991): A surviving implant and/or restoration is defined as are in place at the time of the follow-up.

Secondary

MeasureTime frameDescription
Implant and prosthetic complications10 yearsBiological and/or Technical Implant and prosthetic complications

Countries

Brazil

Contacts

CONTACTManrique Fonseca, Dr
manrique.fonseca@unibe.ch+416840630
STUDY_CHAIRMartin Schimmel, Prof

University of Bern

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026